Literature DB >> 23959158

ARMS2 interference leads to decrease of proinflammatory mediators.

Fanxing Zeng, Min Zhang, Yiting Xu, Haifeng Xu.   

Abstract

BACKGROUND: Age-related macular degeneration (AMD) is a major cause of irreversible blindness among elderly people in developed countries. Many studies suggested that age-related maculopathy susceptibility 2 (ARMS2) is the second major susceptibility gene for AMD. Increasing evidence was found recently that inflammatory processes and oxidative stress may contribute to the pathogenesis of AMD. Meanwhile, the mechanisms underlying the contributions of ARMS2 to the pathogenesis of AMD remain unclear. The purpose of the current study was to elucidate the relationship between the ARMS2 gene and proinflammatory mediators, for further assessment of the associated biologic effects.
METHODS: siRNA was used to knock down ARMS2 mRNA, and Western blotting and reverse real-time PCR were used to detect the effect of siRNA on the expression of ARMS2 in ARPE-19 cells. The expressions of C3, C5, IL-6, IL-8, and TNF-α after si-RNA knockdown were evaluated by SYBR Green I real-time PCR and ELISA.
RESULTS: Transcription accumulative indexes (TAI = 2(-delta delta CT)) of ARMS2 by real-time PCR revealed that the transfection rate in the positive control group was 72.0 ± 2.07 % (P < 0.01). The ratio of absorbance values (by Western blotting) of AMRS2 to β-actin was 0.85 ± 0.122, 0.87 ± 0.143, and 0.61 ± 0.240 in the blank control group, scrambled ARMS2-siRNA group, and ARMS2-siRNA group respectively (F = 42.5, P < 0.01). The secreted protein levels of C3, C5, IL-6, IL-8, and TNF-α were found by ELISA to be reduced by 34.24 ± 1.81 %, 37.15 ± 2.02 %, 35.11 ± 1.75 %, 30.11 ± 2.19 %, and 34.33 ± 2.18 % respectively, in the siRNA-ARMS2 group (P < 0.05). Compared with the blank control group, reduced TAI of C3, C5, IL-6, IL-8, and TNF-α were detected by real-time PCR in the ARMS2-siRNA group.
CONCLUSION: This study produced evidence supporting the notion that the ARMS2 risk allele for AMD is linked directly or indirectly to proinflammatory mediators. More importantly, our data indicate that the change in ARMS2 may affect C3, C5, IL-6, IL-8, and TNF-α levels, and this may be one of the mechanisms of AMD development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959158     DOI: 10.1007/s00417-013-2442-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  32 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

2.  Susceptibility genes for age-related maculopathy on chromosome 10q26.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2005-07-26       Impact factor: 11.025

Review 3.  Age-related macular degeneration.

Authors:  Rama D Jager; William F Mieler; Joan W Miller
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

4.  A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.

Authors:  Zhenglin Yang; Nicola J Camp; Hui Sun; Zongzhong Tong; Daniel Gibbs; D Joshua Cameron; Haoyu Chen; Yu Zhao; Erik Pearson; Xi Li; Jeremy Chien; Andrew Dewan; Jennifer Harmon; Paul S Bernstein; Viji Shridhar; Norman A Zabriskie; Josephine Hoh; Kimberly Howes; Kang Zhang
Journal:  Science       Date:  2006-10-19       Impact factor: 47.728

5.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

6.  Complement factor H variant increases the risk of age-related macular degeneration.

Authors:  Jonathan L Haines; Michael A Hauser; Silke Schmidt; William K Scott; Lana M Olson; Paul Gallins; Kylee L Spencer; Shu Ying Kwan; Maher Noureddine; John R Gilbert; Nathalie Schnetz-Boutaud; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

7.  Analysis of the indel at the ARMS2 3'UTR in age-related macular degeneration.

Authors:  Gaofeng Wang; Kylee L Spencer; William K Scott; Patrice Whitehead; Brenda L Court; Juan Ayala-Haedo; Ping Mayo; Stephen G Schwartz; Jaclyn L Kovach; Paul Gallins; Monica Polk; Anita Agarwal; Eric A Postel; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Hum Genet       Date:  2010-02-25       Impact factor: 4.132

8.  A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.

Authors:  Atsuhiro Kanda; Wei Chen; Mohammad Othman; Kari E H Branham; Matthew Brooks; Ritu Khanna; Shirley He; Robert Lyons; Gonçalo R Abecasis; Anand Swaroop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-20       Impact factor: 11.205

9.  Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria.

Authors:  Gaofeng Wang; Kylee L Spencer; Brenda L Court; Lana M Olson; William K Scott; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-28       Impact factor: 4.799

10.  Age-related macular degeneration-associated variants at chromosome 10q26 do not significantly alter ARMS2 and HTRA1 transcript levels in the human retina.

Authors:  Atsuhiro Kanda; Dwight Stambolian; Wei Chen; Christine A Curcio; Gonçalo R Abecasis; Anand Swaroop
Journal:  Mol Vis       Date:  2010-07-15       Impact factor: 2.367

View more
  6 in total

1.  Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition.

Authors:  Jingjing Zhang; Gongqiang Yuan; Muchen Dong; Ting Zhang; Gao Hua; Qingjun Zhou; Weiyun Shi
Journal:  Histochem Cell Biol       Date:  2016-09-07       Impact factor: 4.304

2.  Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases.

Authors:  Hendrik Faby; Jost Hillenkamp; Johann Roider; Alexa Klettner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-22       Impact factor: 3.117

Review 3.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

Review 4.  Age-related macular degeneration: insights into inflammatory genes.

Authors:  Raffaella Cascella; Michele Ragazzo; Claudia Strafella; Filippo Missiroli; Paola Borgiani; Francesco Angelucci; Luigi Tonino Marsella; Andrea Cusumano; Giuseppe Novelli; Federico Ricci; Emiliano Giardina
Journal:  J Ophthalmol       Date:  2014-11-12       Impact factor: 1.909

5.  Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration.

Authors:  Yutaka Kato; Yasuharu Oguchi; Tomoko Omori; Akihito Kasai; Masashi Ogasawara; Yukinori Sugano; Kanako Itagaki; Akira Ojima; Yumi Ishida; Takeshi Machida; Hideharu Sekine; Tetsuju Sekiryu
Journal:  Ophthalmol Sci       Date:  2022-04-30

6.  Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants.

Authors:  Federico Ricci; Emiliano Giardina; Raffaella Cascella; Claudia Strafella; Giuliana Longo; Michele Ragazzo; Laura Manzo; Cecilia De Felici; Valeria Errichiello; Valerio Caputo; Francesco Viola; Chiara Maria Eandi; Giovanni Staurenghi; Andrea Cusumano; Silvestro Mauriello; Luigi Tonino Marsella; Cinzia Ciccacci; Paola Borgiani; Federica Sangiuolo; Giuseppe Novelli
Journal:  Oncotarget       Date:  2017-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.